Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-04-28
1997-02-25
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544212, 544237, 544234, 544233, 544284, 514248, 514259, C07D40104, A61K 3153, A61K 31445, A61K 3150
Patent
active
056059000
ABSTRACT:
The present invention relates to an adenosine uptake inhibitor and an agent for the myocardium protection or the prevention or treatment of inflammatory edema, comprising a 1,2,3,4-tetrahydro-2,4-dioxoquinazoline derivative represented by formula (I): ##STR1## wherein R.sup.1 represents hydrogen, substituted or unsubstituted lower alkyl, alkenyl, or substituted or unsubstituted aralkyl; R.sup.2, R.sup.3, R.sup.4, and R.sup.5 independently represent hydrogen, halogen, amino, mono- or di(lower alkyl)amino, lower alkanoylamino, nitro, cyano, substituted or unsubstituted lower alkyl, hydroxy, lower alkoxy, lower alkylthio, carboxy, lower alkoxycarbonyl, lower alkanoyl, aralkyloxy, or lower alkanoyloxy; R.sup.6, R.sup.7, R.sup.8, and R.sup.9 independently represent hydrogen, hydroxy, substituted or unsubstituted lower alkoxy, or aralkyloxy, or any adjoining two of them are combined to form methylenedioxy; R.sup.10 represents hydrogen or lower alkyl; and Y and Z independently represent N or C-R.sup.11 (wherein R.sup.11 represents hydrogen, substituted or unsubstituted lower alkyl, or halogen),
or a pharmaceutically acceptable salt thereof as an active ingredient.
REFERENCES:
patent: 4166117 (1979-08-01), Vincent et al.
patent: 4665075 (1987-05-01), Vandenberk et al.
patent: 4668683 (1987-05-01), Takai et al.
patent: 4680296 (1987-07-01), Manoury et al.
Nomoto, Y. et al. Chem. Pharm. Bull., vol. 38, No. 6 (1990) 1591-95.
Young, M. A. et al. Am. J. Physiol., 261, H1570-H1577 (1991).
Dorion, M. et al. J. Cardiovasc. Pharmacol. 19, 69-77 (1992).
Remington's Pharm. Sci., Phila. Coll. Pharm., Phila. (1992) 1286-1292.
Young, M. A. et al. Am. J. Physiol. 261, H1570-H1577 (1991).
Dorion, M. et al. J. Cardiovasc. Pharmacol. 19, 69-77 (1992), abstract from MEDLINE.
Fujiwara Shigeki
Karasawa Akira
Kase Hiroshi
Kawakage Michiyo
Kusaka Hideaki
Kyowa Hakko Kogyo Co. Ltd.
Shah Mukund J.
Wong King Lit
LandOfFree
Benzotriazines having adenosine uptake inhibitor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzotriazines having adenosine uptake inhibitor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzotriazines having adenosine uptake inhibitor activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1974115